This company listing is no longer active
HE6 Stock Overview
Oak Street Health, Inc., together with its subsidiaries, provides healthcare services to the patients in the United States.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 2/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
Oak Street Health, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$35.00 |
52 Week High | US$35.60 |
52 Week Low | US$13.20 |
Beta | 2.23 |
1 Month Change | -1.13% |
3 Month Change | 35.66% |
1 Year Change | 100.00% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -24.73% |
Recent News & Updates
Recent updates
Shareholder Returns
HE6 | DE Healthcare | DE Market | |
---|---|---|---|
7D | -0.6% | 4.1% | -1.5% |
1Y | 100.0% | -0.8% | 0.9% |
Return vs Industry: HE6 exceeded the German Healthcare industry which returned -23.7% over the past year.
Return vs Market: HE6 exceeded the German Market which returned -6.3% over the past year.
Price Volatility
HE6 volatility | |
---|---|
HE6 Average Weekly Movement | 10.7% |
Healthcare Industry Average Movement | 5.6% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.0% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: HE6's share price has been volatile over the past 3 months.
Volatility Over Time: HE6's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2012 | 6,000 | Mike Pykosz | www.oakstreethealth.com |
Oak Street Health, Inc., together with its subsidiaries, provides healthcare services to the patients in the United States. It operates primary care centers for Medicare beneficiaries in Illinois, Michigan, Pennsylvania, Ohio, and Texas. The company was founded in 2012 and is headquartered in Chicago, Illinois.
Oak Street Health, Inc. Fundamentals Summary
HE6 fundamental statistics | |
---|---|
Market cap | €8.65b |
Earnings (TTM) | -€462.61m |
Revenue (TTM) | €1.96b |
4.4x
P/S Ratio-18.7x
P/E RatioIs HE6 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
HE6 income statement (TTM) | |
---|---|
Revenue | US$2.16b |
Cost of Revenue | US$2.08b |
Gross Profit | US$78.10m |
Other Expenses | US$587.30m |
Earnings | -US$509.20m |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
n/a
Earnings per share (EPS) | -2.08 |
Gross Margin | 3.61% |
Net Profit Margin | -23.56% |
Debt/Equity Ratio | -366.1% |
How did HE6 perform over the long term?
See historical performance and comparison